Sanofi & Regeneron announce itepekimab meet the primary endpoint in one of two COPD phase 3 studies: Paris Saturday, May 31, 2025, 10:00 Hrs [IST] The AERIFY-1 phase 3 study evalu ...

By Taylor Sisk KFF Health News In early April, President Donald Trump gathered dozens of hard-hat-clad coal miners around him ...

In patients with diabetic foot ulcers that looked healed and met the current definition of a closed wound, closed ulcers with ...